Canadian Task Force on Preventive Health Care

Summary Table of Recommendations

Screening for Asymptomatic Bacteriuria in Pregnancy

Prepared by Lindsay E. Nicolle, MD, Department of Medicine, University of Manitoba

These recommendations were finalized by the Task Force in October 1993


 
 
MANEUVER EFFECTIVENESS LEVEL OF EVIDENCE <REF> RECOMMENDATION
Screening once by culture method for asymptomatic bacteriuria at 12-16 weeks of pregnancy. Pyelonephritis: Identification and treatment of asymptomatic bacteriuria will decrease the subsequent occurrence of pyelonephritis later in pregnancy and may decrease premature labour or delivery associated with acute pyelonephritis. Controlled trial and cohort studies <1,3-5> (I, II-1) Good evidence to include in periodic health examination of pregnant women. (A)
Intra-uterine growth retardation: Decreased occurrence of intra-uterine growth retardation. Randomized controlled trial <9> (I)
Other: Decreased occurrence of other negative outcomes including premature labour, stillbirth, and pre-eclampsia.

Link to Full Text of this review

Link to Structured Abstract of this review

Link to Selected References list of this review

Top of Page

Home PageCTFPHC Home Page

Reprinted in modified format by the Canadian Task Force on Preventive Health Care
with permission.
Original Copyright © 1994 Minister of Supply and Services Canada.
For any technical issues please contact: webmaster@ctfphc.org
Last modified March 27, 1998.